Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMONO for Peripheral Neuropathic Pain
NCT02957851Phase 2Completed
- Sponsor
- Air Liquide
- Start
- Nov 2016
- Primary completion
- Aug 2018
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 2
01
Overview
Phase 2, randomised, single-blind trial in Peripheral neuropathic pain comparing EMONO with Placebo (2 arms). Primary endpoint: Average Pain Intensity at 7 days. Started Nov 2016; status: completed.
02
Drugs
nitrous oxide + oxygen
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT02957851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02957851.